Larimar Therapeutics, Inc.
LRMR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001374690
In the last 90 days, Larimar Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 163 institutions reported holding it in 13F filings for Q2 2026, worth $291.4M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Larimar Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- −4 vs. Q1 2022
- Shares held
- 14.4M
- −834.2K (−5.5%) vs. Q1 2022
- Total value
- $28.2M
- −$33.4M (−54.2%) vs. Q1 2022
- New holders
- 1
- 4 more added
- Sold out
- 5
- 14 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LRMR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 163 | $291.4M |
| Q1 2026 | 162 | $394.8M |
| Q4 2025 | 136 | $277.0M |
| Q3 2025 | 136 | $274.8M |
| Q2 2025 | 116 | $180.1M |
| Q1 2025 | 103 | $131.9M |
| Q4 2024 | 116 | $245.5M |
| Q3 2024 | 123 | $421.3M |
| Q2 2024 | 107 | $473.5M |
| Q1 2024 | 104 | $482.8M |
| Q4 2023 | 69 | $179.6M |
| Q3 2023 | 65 | $153.0M |
| Q2 2023 | 65 | $120.2M |
| Q1 2023 | 69 | $174.2M |
| Q4 2022 | 48 | $160.1M |
| Q3 2022 | 59 | $123.9M |
| Q2 2022 | 40 | $28.2M |
| Q1 2022 | 45 | $61.8M |
| Q4 2021 | 49 | $157.2M |
| Q3 2021 | 54 | $167.5M |
| Q2 2021 | 45 | $142.8M |
| Q1 2021 | 57 | $206.1M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Larimar Therapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 5,830,249 | $11.4M | 0.24% | 00.0% | Unchanged |
| CHI Advisors LLC | 1,515,148 | $2.97M | 1.14% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 1,031,482 | $2.02M | 0.05% | −250,378−19.5% | Reduced |
| Opaleye Management Inc. | 932,814 | $1.83M | 0.82% | −10,888−1.2% | Reduced |
| Mangrove Partners | 867,812 | $1.70M | 0.13% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 749,068 | $1.48M | 0.00% | −296,177−28.3% | Reduced |
| Morgan Stanley | 529,808 | $1.04M | 0.00% | −1760.0% | Reduced |
| Vanguard Group Inc | 511,082 | $1.00M | 0.00% | 00.0% | Unchanged |
| Verition Fund Management LLC | 403,890 | $792.0K | 0.02% | −20,709−4.9% | Reduced |
| Atlas Venture Advisors, Inc. | 292,184 | $573.0K | 0.18% | 00.0% | Unchanged |
| 683 Capital Management, LLC | 248,800 | $488.0K | 0.04% | −1,200−0.5% | Reduced |
| BlackRock Inc. | 242,108 | $475.0K | 0.00% | −3,748−1.5% | Reduced |
| Driehaus Capital Management LLC | 210,500 | $413.0K | 0.01% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 176,680 | $346.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 175,542 | $344.0K | 0.00% | +2,800+1.6% | Added |
| Fi3 FINANCIAL ADVISORS, LLC | 121,818 | $239.0K | 0.20% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 121,599 | $238.0K | 0.01% | +58,799+93.6% | Added |
| Geode Capital Management, LLC | 113,890 | $223.0K | 0.00% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 51,606 | $100.0K | 0.04% | 00.0% | Unchanged |
| DAFNA Capital Management LLC | 49,996 | $98.0K | 0.03% | 00.0% | Unchanged |
| State Street Corp | 41,450 | $81.0K | 0.00% | 00.0% | Unchanged |
| Difesa Capital Management, LP | 34,550 | $68.0K | 0.05% | −17,500−33.6% | Reduced |
| Royce & Associates LP | 28,064 | $55.0K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 24,738 | $48.0K | 0.00% | −3,400−12.1% | Reduced |
| Two Sigma Investments, LP | 22,712 | $45.0K | 0.00% | −5,700−20.1% | Reduced |
| Northern Trust Corp | 21,330 | $42.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 18,973 | $37.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 13,676 | $27.0K | 0.00% | +779+6.0% | Added |
| Solstein Capital, LLC | 4,477 | $9.00K | 0.01% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 2,004 | $4.00K | 0.00% | −97−4.6% | Reduced |
| US Bancorp | 1,175 | $2.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,262 | $2.00K | 0.00% | +47+3.9% | Added |
| Cutler Group LP | 1,200 | $2.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 601 | $1.00K | 0.00% | −1,132−65.3% | Reduced |
| Citigroup Inc | 275 | $1.00K | 0.00% | −111−28.8% | Reduced |
| Bank of America Corp | 213 | $0 | 0.00% | −116,010−99.8% | Reduced |
| Global Retirement Partners, LLC | 225 | $0 | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 29 | $0 | 0.00% | 00.0% | Unchanged |
| Disciplined Investments, LLC | 116 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 78 | $0 | 0.00% | +78 | New |
| Ghost Tree Capital, LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −55,366−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −13,998−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −46−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −29−100.0% | Sold out |
| Golden State Equity Partners | – | – | – | – | Not filed |